Deerfield Mgmt, L.P. 13D and 13G filings for Esperion Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-05-17 3:06 pm Sale | 2022-05-17 | 13G | Esperion Therapeutics, Inc. ESPR | Deerfield Mgmt, L.P. | 5,000,000 4.990% | -5,000,000 (-50.00%) | Filing |
| 2022-02-11 4:09 pm Unchanged | 2021-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | Deerfield Mgmt, L.P. | 10,000,000 8.060% | 0 (Unchanged) | Filing |
| 2021-12-07 5:19 pm Purchase | 2021-12-07 | 13G | Esperion Therapeutics, Inc. ESPR | Deerfield Mgmt, L.P. | 10,000,000 8.170% | 10,000,000 (New Position) | Filing |